cbdMD (NYSEAMERICAN:YCBD) Shares Down 3.5% – Should You Sell?

cbdMD, Inc. (NYSEAMERICAN:YCBD)’s share price was down 3.5% during trading on Friday . The company traded as low as $0.7150 and last traded at $0.7235. Approximately 326,417 shares traded hands during mid-day trading, an increase of 55% from the average daily volume of 211,087 shares. The stock had previously closed at $0.75.

cbdMD Stock Down 3.5%

The stock has a fifty day simple moving average of $0.79 and a 200 day simple moving average of $0.87.

cbdMD (NYSEAMERICAN:YCBD) last posted its earnings results on Thursday, May 14th. The company reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.03). The business had revenue of $5.64 million during the quarter, compared to the consensus estimate of $5.29 million. cbdMD had a negative return on equity of 33.60% and a negative net margin of 13.29%.

Hedge Funds Weigh In On cbdMD

A hedge fund recently bought a new stake in cbdMD stock. Jane Street Group LLC purchased a new position in shares of cbdMD, Inc. (NYSEAMERICAN:YCBD) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 51,141 shares of the company’s stock, valued at approximately $69,000. Jane Street Group LLC owned about 0.49% of cbdMD at the end of the most recent reporting period. 7.18% of the stock is currently owned by institutional investors.

About cbdMD

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.